Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy
Clinical trial NCT02863354 · COMPLETED
Trial details
- NCT number
- NCT02863354
- Sponsor
- Charles C Wykoff, PhD, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2019-05-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.